Search Results - "OZET, Ahmet"

The role of spleen volume change in predicting immunotherapy response in metastatic renal cell carcinoma by Aslan, Volkan, Karabörk Kiliç, Atiye Cenay, üzet, Ahmet, Ãner, AytuÄ, Günel, Nazan, Yazici, Ozan, SavaÅ, Gözde, Bayrak, Ahmet, Eraslan, Emrah, üksüzoÄlu, Berna, Kiliç, Hüseyin Koray, üzdemir, Nuriye

“…Introduction Resistance to immune checkpoint inhibitors (ICI) is a significant issue in metastatic renal cell carcinoma (mRCC), as it is in the majority of…”
Get full text

Is it necessary to measure basal serum lipid levels in cancer patients prior to tamoxifen treatment? by Sütcüoğlu, Osman, Yazıcı, Ozan, Özet, Ahmet

Get full text

The impact of the expression level of growth differentiation factor 15 in tumor tissue on the response to immunotherapy in non-small cell lung cancer by Akdogan, Orhun, Ogut, Betul, Sutcuoglu, Osman, Sert, Aysenur, Gurler, Fatih, Akyurek, Nalan, Ozdemir, Nuriye, Ozet, Ahmet, Yazici, Ozan

“…Growth differentiation factor-15 (GDF-15), a member of the TGF-β superfamily, is overexpressed in various cancers and facilitates immune evasion by inhibiting…”
Get full text

Prognostic significance of nadir PSA value and time to nadir PSA in patients with metastatic castration-naive prostate cancer receiving first-line hormonotherapy by Inci, Bediz, Gürler, Fatih, Sütcüoglu, Osman, Bastug, Vural, Yazici, Ozan, Üner, Aytug, Özet, Ahmet, Özdemir, Nuriye

“…The current study aimed to evaluate the effect of the time duration to reach the lowest prostate-specific antigen (PSA) from the onset of first-line hormonal…”
Get full text

Clinical features and outcomes of COVID‐19 in patients with solid tumors: Turkish National Registry Data by Özdemir, Nuriye, Dizdar, Ömer, Yazıcı, Ozan, Aksoy, Sercan, Dede, Didem Sener, Budakoğlu, Burçin, Metan, Gökhan, Alp, Alpaslan, Budakoğlu, Isıl Irem, Öksüzoğlu, Ömür Berna Çakmak, Özet, Ahmet, Kılıçkap, Saadettin, Turhal, Nazim Serdar, Çelik, İsmail, Erman, Mustafa, Ata, Naim, Çelik, Osman, Hayran, Mutlu

“…We present demographic, clinical, laboratory characteristics and outcomes of the patients with solid malignancies and novel coronavirus disease (COVID‐19)…”
Get full text

Current status of biosimilars in Turkey: A survey among medical oncologists by Gürler, Fatih, Kasım, Demet Döndü, Kurt İnci, Bediz, Sütçüoğlu, Osman, Ünsal, Oktay, Aslan, Volkan, Tahtacı, Gözde, Özdemir, Nuriye, Üner, Aytuğ, Günel, Nazan, Özet, Ahmet, Yazıcı, Ozan

“…Introduction To evaluate biosimilar understanding and preference trends of medical oncologists in Turkey. Methods A survey consisting of 24 multiple-choice…”
Get full text

A propensity score‐matched comparison of neoadjuvant chemoradiotherapy with cisplatin‐5FU and carboplatin–paclitaxel in locally advanced esophageal squamous cell carcinoma: A Turkish oncology group study by Gürler, Fatih, Tay, Fatih, Sucuoğlu İşleyen, Zehra, Yerlikaya, Tahir, Hendem, Engin, Esen, Selin Aktürk, Sütçüoğlu, Osman, Işık, Deniz, Niğdelioğlu, Büşra, Özen, Miraç, Şahin, Elif, Şakalar, Teoman, Şengül Samancı, Nilay, Alan, Özkan, Hacıbekiroğlu, İlhan, Algın, Efnan, Yılmaz, Melek Karakurt, Türk, Hacı Mehmet, Öksüzoğlu, Berna, Yavuz, Aydın, Yüksel, Osman, Bora, Hüseyin, Yazıcı, Ozan, Özet, Ahmet, Özdemir, Nuriye

“…Background Neoadjuvant treatment is the standard treatment in locally advanced ESCC. However, the optimal chemotherapy regimen is not known. Method This is a…”
Get full text

Carbonic anhydrase IX is a prognostic biomarker in glioblastoma multiforme by Cetin, Bulent, Gonul, Ipek Isık, Gumusay, Ozge, Bilgetekin, Irem, Algin, Efnan, Ozet, Ahmet, Uner, Aytug

“…The identification of prognostic factors in patients with glioblastoma multiforme (GBM) represents an area of increasing interest. Carbonic anhydrase IX…”
Get full text

Retrospective Evaluation of the Efficacy of Gemcitabine-Based Therapies After FOLFIRINOX Failure in Advanced Pancreatic Cancer, Multi-Center Real-Life Data by Sütcüoğlu, Osman, Doğan, Akif, Yilmaz, Funda, Şahin, Ahmet Bilgehan, Şahin, Taha Koray, Esen, Selin Aktürk, Erol, Cihan, Üner, Aytuğ, Özet, Ahmet, Turan, Nedim, Eraslan, Emrah, Deligönül, Adem, Odabaş, Hatice, Günel, Nazan, Uçar, Gökhan, Dede, Didem Şener, Dizdar, Ömer, Çubukçu, Erdem, Öksüzoğlu, Ömür Berna, Emre Yildirim, Mahmut, Yazici, Ozan, Özdemir, Nuriye

“…Combination therapies such as FOLFIRINOX or gemcitabine-nanoparticle albumin-bound paclitaxel (GnP) are recommended for the first-line treatment of patients…”
Get full text

Economic burden of lung cancer in Turkey: A cost of illness study from payer perspective by Cicin, Irfan, Oksuz, Ergun, Karadurmus, Nuri, Malhan, Simten, Gumus, Mahmut, Yilmaz, Ulku, Cansever, Levent, Cinarka, Halit, Cetinkaya, Erdogan, Kiyik, Murat, Ozet, Ahmet

“…Background: This study was designed to estimate economic burden of lung cancer in Turkey from payer perspective based on expert panel opinion on practice…”
Get full text

Safety, efficacy and patient-reported outcomes with trifluridine/tipiracil in pretreated metastatic colorectal cancer: results of the PRECONNECT study by Bachet, Jean-Baptiste, Wyrwicz, Lucjan, Price, Timothy, Cremolini, Chiara, Phelip, Jean-Marc, Portales, Fabienne, Ozet, Ahmet, Cicin, Irfan, Atlan, Dan, Becquart, Martin, Vidot, Loick, Mounedji, Nadjat, Van Cutsem, Eric, Taieb, Julien, Falcone, Alfredo

“…In RECOURSE (, trifluridine/tipiracil significantly improved overall survival and progression-free survival (PFS) versus placebo in patients with pretreated…”
Get full text

Thirty-day mortality rates after immunotherapy initiation by Sütcüoğlu, Osman, İlhan, Ayşegül, Tacar, Seher Yıldız, Güven, Deniz Can, Uçar, Gökhan, Karadurmuş, Nuri, Yıldız, Fatih, Eraslan, Emrah, Uncu, Doğan, Tural, Deniz, Üner, Aytuğ, Günel, Nazan, Özdemir, Nuriye, Kılıçkap, Saadettin, Öksüzoğlu, Ömür Berna, Özet, Ahmet, Yazıcı, Ozan

“…The aim of this study was to determine the cause of death in patients who died within 30 days after the first dose of immunotherapy. The data of 1432 patients…”
Get full text

Evaluation of outcome prediction and disease extension by quantitative 2-deoxy-2-[18F] fluoro-d-glucose with positron emission tomography in patients with small cell lung cancer by Arslan, Nuri, Tuncel, Murat, Kuzhan, Okan, Alagoz, Engin, Budakoglu, Burcin, Ozet, Ahmet, Ozguven, Mehmet Ali

“…Objective The objective of this study is to determine whether 2-deoxy-2-[18F] fluoro- d -glucose with positron emission tomography (FDG-PET) imaging and…”
Get full text

Comparison of Neoadjuvant Chemotherapy Plus Interval Debulking Surgery and Primary Debulking Surgery in Patients with Stage III and IV Ovarian Carcinoma: A Multicenter Real Life Experience by yılmaz, mukaddes

Get full text

PD-L1 expression in immune cells is a favorable prognostic factor for nasopharyngeal carcinoma by Sahinli, Hayriye, Akyürek, Nalan, Yılmaz, Mukaddes, Kandemir, Olcay, Duran, Ayşe, Kulaçoğlu, Sezer, Uçar, Gökhan, Acar, Elif, Özet, Ahmet, Gümüş, Mahmut, Ç. Öksüzoğlu, Ö, Özdemir, Nuriye

“…Background: Programmed death-ligand 1 (PD-L1) has been determined as a reliable prognostic factor for various malignancies. In this study, we aimed to…”
Get full text

Good prognostic factor in patients with nonmetastatic nasopharyngeal carcinoma: Programmed death ligand-1 expression in tumor cells by Sahinli, Hayriye, Akyürek, Nalan, Yılmaz, Mukaddes, Kandemir, Olcay, Duran, Ayşe Ocak, Kulaçoǧlu, Sezer, Uçar, Gökhan, Acar, Elif, Özet, Ahmet, Öksüzoǧlu, O Berna Ç, Özdemir, Nuriye Y

“…Programmed death ligand-1 (PD-L1) is the main ligand for programmed death-1 (PD-1), and is one of the major targets for cancer immunotherapy. Only a few…”
Get full text

Discordances in HER2 status between primary gastric cancer and corresponding metastatic sites by Gumusay, Ozge, Benekli, Mustafa, Ekinci, Ozgur, Baykara, Meltem, Ozet, Ahmet, Coskun, Ugur, Demirci, Umut, Uner, Aytug, Dursun, Ayse, Atak, Ecine Yesim, Buyukberber, Suleyman

“…Determination of human epidermal growth factor receptor-2 status in advanced gastric cancer is important in clinical decision making. In the trastuzumab for GC…”
Get full text

Association between hemoglobin, calcium, and lactate dehydrogenase variability and mortality among metastatic renal cell carcinoma by Cetin, Bulent, Afsar, Barıs, Deger, Serpil Muge, Gonul, Ipek Isık, Gumusay, Ozge, Ozet, Ahmet, Benekli, Mustafa, Coskun, Ugur, Buyukberber, Suleyman

“…Purpose There are no robust data on hemoglobin (Hb), lactate dehydrogenase (LDH), and calcium variability for overall survival (OS) in patients with metastatic…”
Get full text

Abdominal wall perforation in a patient with recurrent epithelial ovarian cancer after bevacizumab treatment by Algin, Efnan, Gumusay, Ozge, Dogan, Mutlu, Ozet, Ahmet

“…Bowel perforation is a rare but well-described complication of bevacizumab, a VEGF monoclonal antibody. However, bevacizumab associated abdominal wall…”
Get full text

Classic Kaposi's sarcoma: A review of 156 cases by Cetin, Bulent, Aktas, Bilge, Bal, Oznur, Algin, Efnan, Akman, Tulay, Koral, Lokman, Kaplan, Mehmet Ali, Demirci, Umut, Uncu, Dogan, Ozet, Ahmet

“…Kaposi's sarcoma (KS) is a reactive, multifocal, multicentric, angiogenic neoplastic proliferation that is thought to originate from endothelial cells that are…”
Get full text